Skip to Main Content

Paper Details

Connectivity Mapping Identifies BI-2536 as a Potential Drug to Treat Diabetic Kidney Disease.
Diabetes
13
2021
BI-2536, DKD, Diabetic Kidney Disease, Diabetic kidney disease, JAK, L1000, NF-B, PLK1, STAT, Smad3, TGF-, TNF-/, diabetic, gene expression signatures, genes, human, kidney failure, kidney injury, mesangial cell, mesangial cells, mice, mouse, proteinuria
Author NameAffiliation
Ge LiangIcahn School of Medicine at Mount Sinai
Ge LiangThe First Affiliated Hospital of Xiamen University
Zichen WangDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Zichen WangDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Ruijie LiuIcahn School of Medicine at Mount Sinai
Zhengzhe LiIcahn School of Medicine at Mount Sinai
Megan L WojciechowiczDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Jiyi HuangThe First Affiliated Hospital of Xiamen University
Kyung LeeIcahn School of Medicine at Mount Sinai
Avi Ma'ayanDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Avi Ma'ayanDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
John Cijiang HeIcahn School of Medicine at Mount Sinai
John Cijiang HeJames J. Peters Veterans Affair Medical Center
  • 1 - 13

Datasets

Release 1.2